Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression

View ORCID ProfileAndré F. Rendeiro, View ORCID ProfileJoseph Casano, View ORCID ProfileCharles Kyriakos Vorkas, Harjot Singh, Ayana Morales, View ORCID ProfileRobert A. DeSimone, Grant B. Ellsworth, Rosemary Soave, View ORCID ProfileShashi N. Kapadia, Kohta Saito, Christopher D. Brown, JingMei Hsu, Christopher Kyriakides, Steven Chiu, View ORCID ProfileLuca Cappelli, Maria Teresa Cacciapuoti, Wayne Tam, View ORCID ProfileLorenzo Galluzzi, Paul D. Simonson, View ORCID ProfileOlivier Elemento, View ORCID ProfileMirella Salvatore, View ORCID ProfileGiorgio Inghirami
doi: https://doi.org/10.1101/2020.09.08.20189092
André F. Rendeiro
1Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for André F. Rendeiro
Joseph Casano
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joseph Casano
Charles Kyriakos Vorkas
4Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charles Kyriakos Vorkas
Harjot Singh
4Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayana Morales
4Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. DeSimone
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert A. DeSimone
Grant B. Ellsworth
4Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosemary Soave
4Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shashi N. Kapadia
4Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
5Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shashi N. Kapadia
Kohta Saito
4Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher D. Brown
4Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JingMei Hsu
6Division of Hematology/Oncology, Department of Medicine Weill Cornell Medicine, New York, NY, 10065, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Kyriakides
7Department of Rehabilitation Medicine at NYU Grossman School of Medicine New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Chiu
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Cappelli
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luca Cappelli
Maria Teresa Cacciapuoti
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wayne Tam
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Galluzzi
2Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA
8Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA
9Sandra and Edward Meyer Cancer Center, New York, NY, USA
10Department of Dermatology, Yale School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lorenzo Galluzzi
Paul D. Simonson
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Elemento
1Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivier Elemento
  • For correspondence: ole2001{at}med.cornell.edu mis2053{at}med.cornell.edu ggi9001{at}med.cornell.edu
Mirella Salvatore
5Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA
11Division of Public Health Programs, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mirella Salvatore
  • For correspondence: ole2001{at}med.cornell.edu mis2053{at}med.cornell.edu ggi9001{at}med.cornell.edu
Giorgio Inghirami
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giorgio Inghirami
  • For correspondence: ole2001{at}med.cornell.edu mis2053{at}med.cornell.edu ggi9001{at}med.cornell.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

With a rising incidence of COVID-19-associated morbidity and mortality worldwide, it is critical to elucidate the innate and adaptive immune responses that drive disease severity. We performed longitudinal immune profiling of peripheral blood mononuclear cells from 45 patients and healthy donors. We observed a dynamic immune landscape of innate and adaptive immune cells in disease progression and absolute changes of lymphocyte and myeloid cells in severe versus mild cases or healthy controls. Intubation and death were coupled with selected natural killer cell KIR receptor usage and IgM+ B cells and associated with profound CD4 and CD8 T cell exhaustion. Pseudo-temporal reconstruction of the hierarchy of disease progression revealed dynamic time changes in the global population recapitulating individual patients and the development of an eight-marker classifier of disease severity. Estimating the effect of clinical progression on the immune response and early assessment of disease progression risks may allow implementation of tailored therapies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project was supported by a Translational Pathology Research COVID-19 grant to G.I., by a ISTM grant to M.S. and by the National Center for Advancing Translational Science of the National Institute of Health Under Award Number UL1TR002384. C.K.V. is supported by NIH K08 AI132739; A.M. is supported by grant KL2TR002385 of the Clinical and Translational Science Center at Weill Cornell Medical College. K.S. is supported by NIH K08 AI139360; C.D.B. is supported by NIH T32 AI07613-19 (PI: Gulick) and by the Kellen Foundation. L.G. is supported by from the Leukemia and Lymphoma Society (LLS), a startup grant from the Dept. of Radiation Oncology at Weill Cornell Medicine (New York, US), a Rapid Response Grant from the Functional Genomics Initiative (New York, US)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Weill Cornell Medicine, IRB 20-03021645

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Quantification of immune cell populations is available as a Supplementary Table file. Hierarchical data format files with single cell data (h5ad) are available as indicated in the repository with source code for the study (https://github.com/ElementoLab/covid-flowcyto) and raw FCS files will be made available upon post-peer review publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 09, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression
André F. Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, Harjot Singh, Ayana Morales, Robert A. DeSimone, Grant B. Ellsworth, Rosemary Soave, Shashi N. Kapadia, Kohta Saito, Christopher D. Brown, JingMei Hsu, Christopher Kyriakides, Steven Chiu, Luca Cappelli, Maria Teresa Cacciapuoti, Wayne Tam, Lorenzo Galluzzi, Paul D. Simonson, Olivier Elemento, Mirella Salvatore, Giorgio Inghirami
medRxiv 2020.09.08.20189092; doi: https://doi.org/10.1101/2020.09.08.20189092
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression
André F. Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, Harjot Singh, Ayana Morales, Robert A. DeSimone, Grant B. Ellsworth, Rosemary Soave, Shashi N. Kapadia, Kohta Saito, Christopher D. Brown, JingMei Hsu, Christopher Kyriakides, Steven Chiu, Luca Cappelli, Maria Teresa Cacciapuoti, Wayne Tam, Lorenzo Galluzzi, Paul D. Simonson, Olivier Elemento, Mirella Salvatore, Giorgio Inghirami
medRxiv 2020.09.08.20189092; doi: https://doi.org/10.1101/2020.09.08.20189092

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3294)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13376)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)